AYTU BioPharma, Inc. (AYTU) Debt by Year
AYTU BioPharma, Inc. carried $9.1M in long-term debt against $26.3M in cash and equivalents at the end of fiscal year 2026. This represents a decrease of 16.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters AYTU BioPharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AYTU Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $9.1M-16.5% | $10.9M+0.2% | $10.9M-26.1% | $14.7M+3.0% | $14.3M+7832.8% | $180K | $0 | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $26.3M-15.0% | $31.0M+54.7% | $20.0M-13.0% | $23.0M+18.7% | $19.4M-61.0% | $49.6M+3.3% | $48.1M+335.4% | $11.0M+57.5% | $7.0M+774.0% | $802K-90.0% | $8.1M+9.5% | $7.4M+178.6% | $2.6M+141664.2% | $2K+1608.3% | $109 |
AYTU Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $9.1M-16.5% | $9.5M+0.1% | $10.0M+0.2% | $10.4M+0.2% | $10.9M+0.2% | $9.5M | $10.0M-33.3% | $10.4M-29.7% | $10.9M-26.1% | N/A | $15.0M+3.1% | $14.8M+9.5% |
| Cash & Equivalents | $26.3M-15.0% | $26.7M+47.0% | $30.0M+47.2% | $32.6M+62.3% | $31.0M+54.7% | $18.2M-8.0% | $20.4M+4.4% | $20.1M+0.7% | $20.0M-13.0% | $19.8M+3.0% | $19.5M+0.1% | $20.0M-16.2% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More AYTU BioPharma, Inc. financials
Frequently Asked Questions
What was AYTU BioPharma, Inc.'s long-term debt in fiscal year 2026?
AYTU BioPharma, Inc. carried $9.1M in long-term debt against $26.3M in cash and equivalents at the end of fiscal year 2026.
How fast is AYTU BioPharma, Inc.'s long-term debt growing?
AYTU BioPharma, Inc. (AYTU) long-term debt fell by 16.5% year over year, from $10.9M to $9.1M in fiscal year 2026.
What was AYTU BioPharma, Inc.'s long-term debt in the most recent quarter?
AYTU BioPharma, Inc. (AYTU) reported $9.1M in long-term debt in Q4 2026. This represents a decrease of 16.5% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what AYTU BioPharma, Inc. (AYTU) reported on that line in every period on record.